51%) were greater (p<0.001) than Day 6 (35%) and 7 (33%), but Day 6 euploid rates were not different from Day 7. Failed amplification rates were similar at 2%, 2%, and 3% on Day 5, 6, and 7, respectively. Euploid rates correlated with blastocyst quality on Day 5 (GOOD ¼ 55%; FAIR ¼ 47%, POOR ¼ 35%) and Day 6 (GOOD ¼ 49%; FAIR ¼ 32%, POOR ¼ 25%). but not on Day 7 (GOOD ¼ 25%; FAIR ¼ 43%, POOR ¼ 30%).Single euploid blastocyst FET pregnancy rates as detailed in Table 1 on Day 5, 6, and 7 were 75%, 63%, 35%, respectively (p<0.01). Furthermore, pregnancy rates were positively correlated to blastocyst quality.CONCLUSIONS: Although Day 7 blastocysts represented only 11% of all the blastocysts biopsied in these PGT-A cycles, the euploid rate was similar to those seen in Day 6 blastocysts, but markedly lower than Day 5 blastocysts. Furthermore, although the blastocyst quality is low in Day 7 biopsied blastocysts with only 7% GOOD quality, 35% of our patients achieved pregnancy from Day 7 single euploid FETs. These results support the continued practice of extended blastocyst culture to Day 7 to increase PGT-A pregnancy rates per retrieval cycle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.